Abstract

Insulin therapy is an integral part of diabetes management in both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). In T1DM, insulin therapy is required from the time of diagnosis and continued to be required over the lifetime of an individual. In T2DM, insulin therapy is used either during acute illness associated with hyperglycaemia and hyperglycaemic emergencies, peri-operatively, or during pregnancy and lactation. Long-term insulin therapy in T2DM is indicated following the failure of combination anti-diabetic therapy with oral or non-insulin injectables to maintain optimal glycaemic control.The pattern of anti-diabetic treatment (especially in type 2 diabetes mellitus) tends to change markedly along with the duration of diabetes including the use of Insulin in its treatment. Studies have reported the benefits of insulin in helping to achieve glycaemic control and reduce the risk of long-term diabetes complications. The data was collected and analysed for compliance and the errors were detected. Corrective actions were taken and a re-audit was done to check the compliance. The implementation of a structured documentation form together with training measures for health-care-professionals led to less documentation errors and safe management of glycemic control in hospitalized patients in a short time follow-up.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call